Intermittent fasting cuts Crohn's disease activity by 40% and halves inflammation in randomized clinical trial

A randomized controlled study found that time-restricted feeding—a form of intermittent fasting—significantly reduced symptomatic disease activity and systematic inflammation in adults with Crohn's disease and overweight or obesity. Results of the study were published in Gastroenterology.